Enhanced diagnostic signatures for patient stratification and improved clinical management of human disease.

 

Learn More

 

Enhanced diagnostic signatures for patient stratification and improved clinical management of human disease

 

Learn More

Welcome to resolomics

Resolomics is a biotechnology company developing innovative, high-value companion diagnostics and a novel cell-based therapy.

Product Focus

Initial product focus is on: Rheumatoid Arthritis, Cardiovascular Disease, Sepsis & Trauma where substantial unmet clinical need exists.

Rheumatoid Arthritis

Cardiovascular Disease

Sepsis & Trauma

Our Technology

Our technology can be applied across all inflammatory diseases, both chronic and acute.

Contact Us

To find out more about Resolomics and our technology, please get in touch with our team.

Resolomics Limited

About Resolomics

Enhanced diagnostic signatures for patient stratification and improved clinical management of human diseases

Get in touch
+44 (0)20 7882 5278

info@resolomics.com

Resolomics ltd

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square
LONDON EC1M 6BQ